Markets:

Overview

News

Currencies

International

Treasuries

Intuitive Surgical (NQ:ISRG)

455.12 +2.45 (+0.54%)

Streaming Delayed Price Updated: 11:23 AM EDT, Mar 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Intuitive Surgical

< Previous 1 2 3 4 5 6 7 8 9

...

58 59 Next >

Intuitive Surgical Stock Climbs After Company Tops Q4 Earnings ↗

January 22, 2026

Intuitive Surgical Inc (NASDAQ:ISRG) reports financial results for the fourth quarter on Thursday. Here's a rundown of the report.

Via Benzinga

Intuitive Surgical (NASDAQ:ISRG) Delivers Impressive Q4 CY2025

January 22, 2026

Medical technology company Intuitive Surgical (NASDAQ:ISRG) announced better-than-expected revenue in Q4 CY2025, with sales up 18.8% year on year to $2.87 billion. Its non-GAAP profit of $2.53 per...

Via StockStory

Intuitive Announces Fourth Quarter Earnings

January 22, 2026

From Intuitive Surgical, Inc.

Via GlobeNewswire

Resilience in the Face of the Patent Cliff: Johnson & Johnson Forecasts Landmark 2026 Growth

January 22, 2026

NEW BRUNSWICK, N.J. – Johnson & Johnson (NYSE: JNJ) has signaled a definitive turning point in its corporate evolution, issuing a robust 2026 financial outlook that defies the gravity of the...

Via MarketMinute

Where Will Intuitive Surgical Be in 5 Years? ↗

January 21, 2026

The bullish case for the stock remains strong.

Via The Motley Fool

Intuitive Surgical (ISRG) Q4 Earnings Report Preview: What To Look For

January 20, 2026

Medical technology company Intuitive Surgical (NASDAQ:ISRG) will be reporting earnings this Thursday after the bell. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

The Titan’s Balance: Johnson & Johnson Reaches Record Highs Amidst Legal Hurdles and Med-Tech Transformation

January 20, 2026

As the healthcare industry looks toward 2026, Johnson & Johnson (NYSE: JNJ) stands at a historic crossroads, reinforcing its reputation as the ultimate bellwether for the global healthcare sector. On...

Via MarketMinute

Topics Bankruptcy Lawsuit World Trade

2 Healthcare Names That Could Get a Big Boost From Earnings ↗

January 20, 2026

Via MarketBeat

The High-Stakes Balancing Act: Johnson & Johnson Braces for Q4 Earnings Amid Patent Cliffs and MedTech Expansion

January 20, 2026

As the opening bell approaches on January 21, 2026, all eyes on Wall Street are fixed on Johnson & Johnson (NYSE: JNJ), which is set to report its fourth-quarter and full-year 2025 financial results....

Via MarketMinute

Topics Bankruptcy Earnings Economy

The Best Healthcare Stocks to Buy With $5,000 in 2026 and Hold Forever ↗

January 19, 2026

All three of these healthcare giants are leaders in their niches.

Via The Motley Fool

Topics Artificial Intelligence

The New Era of Johnson & Johnson: A 2026 Deep-Dive Research Feature

January 19, 2026

As of January 19, 2026, Johnson & Johnson (NYSE: JNJ) stands as a radically different enterprise than the one most investors recognized just three years ago. Following the successful spin-off of its...

Via Finterra

Topics Artificial Intelligence Bankruptcy Economy

My Forever Portfolio: 5 Stocks I Don't Plan on Ever Selling ↗

January 19, 2026

These stocks are definitely keepers.

Via The Motley Fool

Topics Artificial Intelligence

2 Large-Cap Stocks with Promising Prospects and 1 We Avoid

January 18, 2026

Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for...

Via StockStory

Topics Supply Chain

Healthcare Titan Ascendant: Johnson & Johnson Hits All-Time Highs as It Navigates a New Political and Clinical Era

January 15, 2026

As of January 15, 2026, Johnson & Johnson (NYSE: JNJ) has emerged as the undisputed pacesetter of the healthcare sector, with its stock price surging to an all-time high of $218.53. This milestone...

Via MarketMinute

Topics Artificial Intelligence Bankruptcy Earnings

Rule Breaker Investing: A "Secret Weapon" for Investors ↗

January 14, 2026

This lesson-filled episode makes the case for capital "H" History as an investor's secret weapon -- and for why perspective, patience, and precise thinking continue year after year to help investors...

Via The Motley Fool

Why Intuitive Surgical Stock Dropped Today ↗

January 14, 2026

Would you pay 71x earnings for a growth stock that's slowing down?

Via The Motley Fool

Topics Earnings

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030 ↗

January 14, 2026

Plenty of growth lies ahead for these top healthcare companies.

Via The Motley Fool

Which S&P500 stocks are gapping on Wednesday? ↗

January 14, 2026

Via Chartmill

Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Results

January 14, 2026

From Intuitive Surgical, Inc.

Via GlobeNewswire

1 Nasdaq 100 Stock to Consider Right Now and 2 Facing Headwinds

January 13, 2026

While the Nasdaq 100 (^NDX) is filled with cutting-edge technology and consumer companies, not all are on solid footing. Some are dealing with declining demand, high costs, or regulatory pressures that...

Via StockStory

Wall Street Sets Its Sights on 8,000: Why the S&P 500 Bull Run Is Gaining Momentum for 2026

January 13, 2026

As the trading floor lights flickered to life in early 2026, a new psychological benchmark took hold of the financial world: 8,000. Just two years after the S&P 500 first crossed the 5,000 threshold, a...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Healthcare Bellwether Braces for Impact: UnitedHealth Group’s High-Stakes Q4 Outlook Signals a Sector-Wide Reset

January 13, 2026

As the 44th Annual J.P. Morgan Healthcare Conference kicked off this week in San Francisco, all eyes turned to UnitedHealth Group (NYSE:UNH), the diversified healthcare giant that serves as the primary...

Via MarketMinute

Topics Earnings Economy Stocks

1 Cash-Heavy Stock to Consider Right Now and 2 We Question

January 12, 2026

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Via StockStory

This Fund Dumped a $16 Million Waystar Stake as Shares Lagged the Market by Nearly 30 Points ↗

January 10, 2026

Waystar specializes in cloud-based payment solutions for the healthcare industry, serving providers with financial and analytics tools.

Via The Motley Fool

Topics Regulatory Compliance

The Rubin Revolution vs. The Great Rotation: Nvidia’s Rollercoaster Start to 2026

January 09, 2026

The first trading week of 2026 has delivered a complex narrative for the technology sector, defined by a stark contrast between groundbreaking innovation and a massive institutional shift in capital....

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Is This Robotic Surgery Titan the Secret to 100% Gains by 2030? ↗

January 06, 2026

Demand for robotic surgery is growing faster than the number of surgical robots being sold.

Via The Motley Fool

The Great 2026 Pivot: Tech and Healthcare Surge as Broader Market Rally Hits a Wall

January 06, 2026

As the first week of 2026 comes to a close, the financial markets are undergoing a significant structural shift. The broad-based "rising tide" that lifted almost all sectors throughout 2025 has begun...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

2 Soaring Stocks to Hold for the Next 20 Years ↗

January 06, 2026

If you are looking for growth stocks that have solid long-term prospects, Costco and Intuitive Surgical should be on your short list.

Via The Motley Fool

My 10 Top Stocks to Buy to Start the New Year Off Right ↗

January 05, 2026

Investing in a few of these players could increase the diversification of your portfolio.

Via The Motley Fool

Topics Artificial Intelligence

2 Cash-Producing Stocks to Keep an Eye On and 1 Facing Headwinds

January 04, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

58 59 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.